Synthesis and study of psychotropic and hypotensive properties of new picamilon derivatives

This is a preview of subscription content, access via your institution.

References

  1. 1.

    USSR Inventor's Certificate No. 325 232,Byull. Izobret., No. 3 (1972).

  2. 2.

    Picamilon in Modern Neurological and Psychiatric Practice [in Russian], “Vitaminy” Research and Production Association, Moscow (1994).

  3. 3.

    P. M. Vasil'ev, G. V. Kovalev, and N. V. Mukhina,Picamilon: A New Cerebrovascular and Nootropic Drug [in Russian], VNIISENTI, Moscow (1989), pp. 60–61.

    Google Scholar 

  4. 4.

    T. A. Voronina, T. L. Garibova, I. V. Khromova, et al.,Farmakol. Toxicol.,50(3), 21–24 (1987).

    CAS  Google Scholar 

  5. 5.

    T. A. Voronina and G. M. Molodavkin,Picamilon in Modern Neurological and Psychiatric Practice [in Russian], “Vitaminy” Research and Production Association, Moscow (1994), pp. 38–41.

    Google Scholar 

  6. 6.

    E. A. Kuznetsova, T. A. Voronina, I. V. Khromova, et al.,Khim.-Farm. Zh.,23(12), 1425–1431 (1989).

    CAS  Google Scholar 

  7. 7.

    L. A. Zhmurenko, S. A. Borisenko, O. M. Glozman, et al.,Khim.-Farm. Zh.,14(9), 45–55 (1980).

    Google Scholar 

  8. 8.

    G. I. Kovalev, V. M. Kopelevich, L. N. Bulanova, et al.,Khim.-Farm. Zh.,13(10), 18–23 (1979).

    CAS  Google Scholar 

  9. 9.

    K. Matsuyama, C. Yamashita, A. Noda, et al.,Chem. Pharm. Bull.,32, 4089–4095 (1984).

    PubMed  CAS  Google Scholar 

  10. 10.

    R. S. Mirzoyan, T. S. Gan'shina, and L. M. Shmuilovich,Byul. Eksp. Biol. Med., No. 11, 573–574 (1981).

    Google Scholar 

  11. 11.

    T. A. Voronina, O. M. Glozman, L. M. Meshcheryakova, et al.,Khim.-Farm. Zh.,29(12), 134–37 (1995).

    Google Scholar 

  12. 12.

    W. H. Gundel,Z. Naturforsch.,40B, 305–312 (1985).

    Google Scholar 

  13. 13.

    R. A. Khaunina and I. P. Lapin,Khim.-Farm. Zh.,10(12), 125–127 (1976).

    CAS  Google Scholar 

  14. 14.

    G. Pepeu,Alzheimer's Disease, (1989), pp. 387–398.

  15. 15.

    R. Porsolt, G. Anton, N. Blavet, et al.,Eur. J. Pharmacol.,47, 379–391 (1978).

    PubMed  CAS  Article  Google Scholar 

  16. 16.

    R. M. Salimov,Zh. Vyssh. Nerv. Deyat.,38 (3), 569–570 (1988).

    CAS  Google Scholar 

  17. 17.

    J. Bures and O. Buresova,J. Physiol. Psychol.,56, 268–272 (1963).

    CAS  Article  Google Scholar 

  18. 18.

    A. A. Krauklis,Self-Regulation of Higher Nervous Activity [in Russian], Riga (1964), p. 326.

  19. 19.

    N. A. Bondarenko,Author's Abstract of Cand. Sci. (Biol.) Thesis, Moscow (1992).

  20. 20.

    M. L. Belen'kii,Principles of the Quantitative Assessment of the Pharmacological Effect [in Russian], Medgiz, Leningrad (1963).

    Google Scholar 

  21. 21.

    H. Takahashi and M. Tiba,Jpn. J. Physiol.,5, 334–339 (1955).

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 31, No. 10, pp. 30–33, October, 1997.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kopelevich, V.M., Bulanova, L.N., Grigor'ev, I.A. et al. Synthesis and study of psychotropic and hypotensive properties of new picamilon derivatives. Pharm Chem J 31, 536–539 (1997). https://doi.org/10.1007/BF02464261

Download citation

Keywords

  • Forced Swimming Test
  • Dark Compartment
  • Immobilization Time
  • Blind Alley
  • Isonicotinoyl